GILD insider transactions
Gilead Sciences Inc. (GILD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GILD
- Chairman & CEO O'Day Daniel Patrick sold $1,971,847 worth of shares (15,000 units at $131.46) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 617,567 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $396,810 worth of shares (3,000 units at $132.27) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 173,191 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna exercised 25,000 shares at a strike of $66.64 and sold $3,676,199 worth of shares (28,000 units at $131.29) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 125,779 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Bluestone Jeffrey was granted 1,146 shares, increasing direct ownership by 13% to 10,066 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Barton Jacqueline K was granted 1,146 shares, increasing direct ownership by 4% to 27,202 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Horning Sandra was granted 1,146 shares, increasing direct ownership by 22% to 6,293 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Love Ted W was granted 1,146 shares, increasing direct ownership by 26% to 5,484 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Rodriguez Javier was granted 1,146 shares, increasing direct ownership by 9% to 13,364 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Welters Anthony was granted 1,146 shares, increasing direct ownership by 10% to 12,894 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Manwani Harish was granted 1,146 shares and covered exercise/tax liability with 224 shares, increasing direct ownership by 7% to 15,015 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by Director Kramer Kelly A.4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,291,608 worth of shares (10,000 units at $129.16) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 632,567 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by Dickinson Andrew D4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by Mercier Johanna4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by O'Day Daniel Patrick4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna sold $432,690 worth of shares (3,000 units at $144.23), decreasing direct ownership by 2% to 131,779 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $432,690 worth of shares (3,000 units at $144.23), decreasing direct ownership by 2% to 179,191 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D converted options into 6,469 shares and covered exercise/tax liability with 3,147 shares, increasing direct ownership by 2% to 182,191 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna converted options into 6,617 shares and covered exercise/tax liability with 3,216 shares, increasing direct ownership by 3% to 134,779 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- EVP Gen Counsel, Legal & Comp Cain Wettan Keeley M converted options into 1,246 shares and covered exercise/tax liability with 606 shares, increasing direct ownership by 14% to 5,054 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by SVP, Controllership Burkhart Erin4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick converted options into 20,026 shares and covered exercise/tax liability with 9,767 shares, increasing direct ownership by 2% to 652,567 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Medical Officer Berger Dietmar converted options into 2,133 shares and covered exercise/tax liability with 1,063 shares, increasing direct ownership by 6% to 18,982 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D was granted 11,090 shares, increasing direct ownership by 7% to 178,869 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna was granted 11,090 shares, increasing direct ownership by 9% to 131,378 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Medical Officer Berger Dietmar was granted 8,530 shares, increasing direct ownership by 91% to 17,912 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- EVP Gen Counsel, Legal & Comp Cain Wettan Keeley M was granted 470 shares, increasing direct ownership by 12% to 4,414 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick was granted 38,396 shares and sold $1,447,859 worth of shares (10,000 units at $144.79), increasing direct ownership by 5% to 642,308 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna exercised 25,000 shares at a strike of $66.64 and sold $4,324,228 worth of shares (28,000 units at $154.44), decreasing direct ownership by 2% to 120,288 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $463,290 worth of shares (3,000 units at $154.43), decreasing direct ownership by 2% to 167,779 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- New insider Cain Wettan Keeley M claimed ownership of 3,944 shares (SEC Form 3)3 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick exercised 115,640 shares at a strike of $66.01 and sold $17,346,000 worth of shares (115,640 units at $150.00) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Comm & Corp Aff Officer Mercier Johanna was granted 44,867 shares and covered exercise/tax liability with 24,800 shares, increasing direct ownership by 19% to 123,288 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D was granted 44,867 shares and covered exercise/tax liability with 24,802 shares, increasing direct ownership by 13% to 170,568 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick was granted 131,675 shares and covered exercise/tax liability with 74,461 shares, increasing direct ownership by 10% to 613,912 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,398,911 worth of shares (10,000 units at $139.89), decreasing direct ownership by 2% to 556,698 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick exercised 115,640 shares at a strike of $66.01 and sold $15,611,400 worth of shares (115,640 units at $135.00) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Bluestone Jeffrey exercised 5,000 shares at a strike of $67.45 and sold $617,500 worth of shares (5,000 units at $123.50) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $372,930 worth of shares (3,000 units at $124.31), decreasing direct ownership by 2% to 150,503 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Commercial Officer Mercier Johanna sold $372,930 worth of shares (3,000 units at $124.31), decreasing direct ownership by 3% to 103,221 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Medical Officer Berger Dietmar converted options into 16,326 shares and covered exercise/tax liability with 6,944 shares (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,248,272 worth of shares (10,000 units at $124.83), decreasing direct ownership by 2% to 566,698 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $366,000 worth of shares (3,000 units at $122.00), decreasing direct ownership by 2% to 153,503 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Commercial Officer Mercier Johanna sold $366,000 worth of shares (3,000 units at $122.00), decreasing direct ownership by 3% to 106,221 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D converted options into 3,693 shares and covered exercise/tax liability with 1,745 shares, increasing direct ownership by 1% to 156,503 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick converted options into 10,426 shares and covered exercise/tax liability with 4,931 shares, increasing direct ownership by 0.96% to 576,698 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Commercial Officer Mercier Johanna covered exercise/tax liability with 1,814 shares and converted options into 3,842 shares, increasing direct ownership by 2% to 109,221 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Bluestone Jeffrey exercised 5,000 shares at a strike of $64.92 and sold $625,400 worth of shares (5,000 units at $125.08) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Director Kramer Kelly A. exercised 5,611 shares at a strike of $81.00 and sold $713,186 worth of shares (5,611 units at $127.11) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,265,444 worth of shares (10,000 units at $126.54), decreasing direct ownership by 2% to 571,203 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $313,075 worth of shares (2,500 units at $125.23), decreasing direct ownership by 2% to 154,555 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Commercial Officer Mercier Johanna exercised 25,000 shares at a strike of $66.64 and sold $3,524,173 worth of shares (28,000 units at $125.86), decreasing direct ownership by 3% to 107,193 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- EVP, Corporate Affairs & GC Telman Deborah H exercised 53,646 shares at a strike of $65.35 and sold $6,590,487 worth of shares (53,646 units at $122.85) (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,193,926 worth of shares (10,000 units at $119.39), decreasing direct ownership by 2% to 581,203 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- EVP, Corporate Affairs & GC Telman Deborah H converted options into 515 shares and covered exercise/tax liability with 241 shares, increasing direct ownership by 0.63% to 43,676 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Financial Officer Dickinson Andrew D sold $295,200 worth of shares (2,500 units at $118.08), decreasing direct ownership by 2% to 157,055 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chief Commercial Officer Mercier Johanna sold $354,240 worth of shares (3,000 units at $118.08), decreasing direct ownership by 3% to 110,193 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- Chairman & CEO O'Day Daniel Patrick sold $1,116,564 worth of shares (10,000 units at $111.66), decreasing direct ownership by 2% to 591,203 units (SEC Form 4)4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 4 filed by SVP, Controllership Burkhart Erin4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
- SEC Form 3 filed by new insider Burkhart Erin3 - GILEAD SCIENCES, INC. (0000882095) (Issuer)